ACT to Reduce Morbidity and Mortality in Hematopoietic Stem Cell Transplant Patients
Starting soon · Not applicable
Conditions studied: Stem Cell Transplant Patients
In brief
This study is a phase 2, multicenter, randomized controlled trial to test the application of Acceptance and Commitment Therapy (ACT) in HCT patients. ACT is an evidence-based cognitive behavioral therapy intervention that emphasizes psychological flexibility and behaviors, helping transplant patients focus on actions that may help maintain adequate physical activity despite physical and emotional discomfort.
Key facts
- Study ID
- NCT07516314
- Run by
- Anthony Sung, MD
- People needed
- 476
- Starts
- 2026-05-01
- Expected to finish
- 2031-04-01
- Last updated by the study team
- 2026-04-07
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.
Where it is running
- University of Kansas Cancer Center — Kansas City, Kansas, United States
- Duke University — Durham, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.